The NAD+ market has an evidence problem, not a shortage of products. A supplement can raise a measured metabolite without demonstrating improved memory, more energy or longer life. Meanwhile, clinics may sell NAD+ infusions or injections under a similar “restore your levels” storyline. If you are comparing these options, learn to recognize what a study actually measured before you trust the headline.
Understand what the study measured
An NAD-related blood or tissue marker may be a useful research measurement. It is not automatically a meaningful outcome for a patient. Ask whether researchers measured symptoms, physical function, cognition or long-term disease risk, and whether those outcomes improved. A figure showing increased metabolites cannot by itself support a marketing claim about reversing biological aging.
Look for human comparison groups
Animal research can help explain mechanisms but cannot establish a treatment benefit in people. Human trials should report who participated, what was compared, the duration, adverse events and the size of the effect. Short studies in healthy volunteers often leave practical questions unresolved. Be skeptical when a product page quotes an animal mechanism as though it were a human medical result.
Keep NAD+, NMN and NR distinct
NAD+ is a coenzyme, while NMN and NR are precursor molecules with different pathways and commercial forms. They cannot be treated as interchangeable products simply because their marketing stories reference NAD biology. Oral supplements and sterile injections also raise different safety and regulatory questions. A fair comparison states the molecule, formulation, route and actual studied dose without pretending one study applies to all versions.
Separate sponsorship from evidence
A study sponsored by a manufacturer is not automatically invalid, but its design, reported endpoints, statistical analysis and publication details deserve scrutiny. Look for pre-specified outcomes and meaningful human comparison groups. Affiliate publishers should disclose paid links and avoid assigning a clinical winner based on commission rate or provider advertising copy.
Ask the most useful personal question
Instead of “Which supplement is best for longevity?” ask “What clinical outcome do I hope to improve, and is there reliable human evidence this product improves it?” If you are considering an NAD+ injection, ask about sterile compounding safeguards and discuss medical risks with a qualified clinician. No consumer comparison should promise anti-aging or cognitive benefits that are unproven.
Save this checklist
- Biomarker versus clinical endpoint identified
- Human randomized comparison groups, if available
- Duration and sample size disclosed
- Exact ingredient, route and formulation named
- Funding and conflicts of interest reviewed
- Adverse events and limitations included
Two questions readers ask
Does raising NAD-related markers mean you will live longer?
No. That conclusion would require appropriate long-term human clinical evidence.
Can one NAD+ injection study prove benefits of NMN capsules?
No. Different products and delivery routes require their own supporting evidence.
The principle is the same no matter which provider advertises the lowest price: obtain the exact proposed product, the clinical and pharmacy path, and the written service terms. A commission arrangement should never determine a medical recommendation.
Compare the care pathway and ask about current provider eligibility, product status, price and prescribing requirements. This is a referral route only; we have not independently confirmed current medication inventory, clinical suitability, or your eligibility.
Review the advertised care program ↗Paid link: we may earn commission. Nothing here guarantees a prescription or health outcome.